PMID- 24927914 OWN - NLM STAT- MEDLINE DCOM- 20150413 LR - 20151119 IS - 1532-3102 (Electronic) IS - 0143-4004 (Linking) VI - 35 IP - 8 DP - 2014 Aug TI - Inflammation-induced fetal growth restriction in rats is associated with altered placental morphometrics. PG - 575-81 LID - S0143-4004(14)00194-5 [pii] LID - 10.1016/j.placenta.2014.05.002 [doi] AB - INTRODUCTION: Evidence links alterations in placental shape and size to fetal growth restriction (FGR). Here we determined whether alterations in placental morphometrics are linked to FGR induced by abnormal maternal inflammation. METHODS: We used an inflammation-induced model of FGR in which pregnant rats receive lipopolysaccharide (LPS) on gestational days (GD) 13.5-16.5. Fetal weights were matched to various parameters of placental morphometrics including weight, area, minor and major axes lengths and thickness. RESULTS: Compared with saline administration, LPS administration was associated with altered placental morphometrics, including reduced placental weight, decreased placental area and a trend towards reduced placental thickness. When data were dichotomized as FGR or normal-sized fetuses within treatment groups, a significant increase in the placental-weight-to-fetal-weight ratio and placental thickness was observed only in the saline-associated FGR subgroup. Multivariable linear regression revealed that the lengths of the major and minor placental axes were predictors of fetal weight, regardless of treatment modality. Subgroup regression analysis by treatment revealed that the lengths of the major and minor placental axes were predictors of fetal weight in the saline-treatment group while only the minor placental axis was a predictor of fetal weight in the LPS cohort. Finally, placental area and the length of the minor placental axis were correlated with implantation site location only in the saline-treatment group. DISCUSSION/CONCLUSION: These findings indicate that inflammation-induced FGR is associated with alterations in placental morphometrics. Our data reveal that the mechanisms leading to inflammation-induced FGR may be different from the mechanisms leading to idiopathic FGR. CI - Copyright (c) 2014 Elsevier Ltd. All rights reserved. FAU - Cotechini, T AU - Cotechini T AD - Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario K7L 3N6, Canada. Electronic address: 4tc16@queensu.ca. FAU - Hopman, W J AU - Hopman WJ AD - Clinical Research Centre, Kingston General Hospital, Kingston, Ontario, Canada; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada. FAU - Graham, C H AU - Graham CH AD - Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario K7L 3N6, Canada. Electronic address: grahamc@queensu.ca. LA - eng GR - MOP 119496/Canadian Institutes of Health Research/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140520 PL - Netherlands TA - Placenta JT - Placenta JID - 8006349 RN - 0 (Lipopolysaccharides) RN - 451W47IQ8X (Sodium Chloride) SB - IM MH - Animals MH - Disease Models, Animal MH - Embryo Implantation MH - Female MH - Fetal Development MH - Fetal Growth Retardation/*immunology/pathology MH - Fetal Weight MH - Linear Models MH - Lipopolysaccharides MH - Placenta/pathology MH - *Placentation MH - Pregnancy MH - Rats, Wistar MH - Sodium Chloride OTO - NOTNLM OT - Fetal growth restriction OT - Inflammation OT - Minor axis OT - Placenta OT - Placental morphometry OT - Pre-eclampsia EDAT- 2014/06/15 06:00 MHDA- 2015/04/14 06:00 CRDT- 2014/06/15 06:00 PHST- 2014/01/24 00:00 [received] PHST- 2014/03/25 00:00 [revised] PHST- 2014/05/07 00:00 [accepted] PHST- 2014/06/15 06:00 [entrez] PHST- 2014/06/15 06:00 [pubmed] PHST- 2015/04/14 06:00 [medline] AID - S0143-4004(14)00194-5 [pii] AID - 10.1016/j.placenta.2014.05.002 [doi] PST - ppublish SO - Placenta. 2014 Aug;35(8):575-81. doi: 10.1016/j.placenta.2014.05.002. Epub 2014 May 20.